Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

Xiangxue Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	7,195	6,018	6,461	3,406	3,961	5,266
Market Cap Growth	109.23%	-6.86%	89.71%	-14.02%	-24.79%	-9.85%
Enterprise Value	8,875	8,515	9,128	6,159	6,816	9,064
Last Close Price	10.88	9.10	9.77	5.15	6.07	8.07
Forward PE	-	11.93	11.93	11.93	11.93	11.93
PS Ratio	4.71	3.77	3.48	1.48	1.81	1.77
PB Ratio	-85.56	136.93	4.49	1.47	1.46	1.40
P/TBV Ratio	-	-	437.03	4.23	3.47	3.20
P/FCF Ratio	52.87	50.95	-	16.42	-	-
P/OCF Ratio	46.09	43.10	355.48	12.93	17.42	20.45
EV/Sales Ratio	5.81	5.34	4.91	2.68	3.12	3.05
EV/EBITDA Ratio	52.96	74.92	-	21.82	113.06	72.50
EV/EBIT Ratio	-	-	-	123.98	-	-
EV/FCF Ratio	65.21	72.09	-	29.69	-	-
Debt / Equity Ratio	-17.09	33.38	1.56	1.05	0.90	0.92
Debt / EBITDA Ratio	8.55	10.13	-	8.48	38.38	27.04
Debt / FCF Ratio	10.56	12.42	-	11.73	-	-
Net Debt / Equity Ratio	-15.37	27.59	1.46	0.99	0.84	0.82
Net Debt / EBITDA Ratio	9.44	10.67	-133.61	8.09	38.01	24.64
Net Debt / FCF Ratio	9.50	10.26	-122.94	11.01	-16.38	-10.10
Asset Turnover	0.22	0.22	0.24	0.27	0.22	0.25
Inventory Turnover	3.37	3.64	3.86	3.54	2.69	2.78
Quick Ratio	0.16	0.18	0.19	0.19	0.18	0.28
Current Ratio	0.24	0.26	0.30	0.35	0.32	0.44
Return on Equity (ROE)	-217.95%	-184.89%	-45.91%	-15.96%	-15.58%	-16.45%
Return on Assets (ROA)	-0.41%	-0.67%	-1.85%	0.37%	-1.09%	-0.12%
Return on Invested Capital (ROIC)	-3.76%	-3.20%	-5.75%	1.03%	-2.96%	-0.31%
Return on Capital Employed (ROCE)	-60.40%	-13.30%	-11.10%	1.60%	-5.10%	-0.50%
Earnings Yield	-19.68%	-23.14%	-13.29%	-11.42%	-13.38%	-13.07%
FCF Yield	1.89%	1.96%	-0.26%	6.09%	-3.53%	-5.79%
Buyback Yield / Dilution	-0.63%	0.10%	-0.18%	0.50%	-0.09%	-0.89%
Total Shareholder Return	-0.63%	0.10%	-0.18%	0.50%	-0.09%	-0.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.